Klin Onkol 2024; 37(6): 433-444.
DOI: 10.48095/ccko2024433.
Keywords: lung cancer – real-world evidence – patient registry
Authors: Bílek Ondřej, Selingerová Iveta, Kysela Michal, Jedlička Václav, Kazda Tomáš, Berkovcová Jitka, Turčáni Pavel, Poprach Alexandr, Kiss Igor, Svoboda Marek, Zdražilová Dubská Lenka2024-12-15:Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018–2022
Keywords: lung cancer – real-world evidence – patient registry
Authors: Bílek Ondřej, Selingerová Iveta, Kysela Michal, Jedlička Václav, Kazda Tomáš, Berkovcová Jitka, Turčáni Pavel, Poprach Alexandr, Kiss Igor, Svoboda Marek, Zdražilová Dubská Lenka2024-12-15:Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018–2022
Klin Onkol 2024; 37(6): 445-450.
DOI: 10.48095/ccko2024445.
Keywords: chemotherapy – second line – melanoma – immunotherapy – targeted therapy – dacarbazine
Authors: Šulc David2024-12-15:Chemotherapy as an optimal treatment option after failure of immunotherapy and targeted therapy in advanced and metastatic melanoma
Keywords: chemotherapy – second line – melanoma – immunotherapy – targeted therapy – dacarbazine
Authors: Šulc David2024-12-15:Chemotherapy as an optimal treatment option after failure of immunotherapy and targeted therapy in advanced and metastatic melanoma
Klin Onkol 2024; 37(6): 451-462.
DOI: 10.48095/ccko2024451.
Keywords: Waldenström’s macroglobulinemia – bortezomib – ixazomib
Authors: Adam Zdeněk, Krejčí Marta, Pour Luděk, Weinbergerová Barbora, Sandecká Viera, Štork Martin, Boichuk Ivanna, Řehák Zdeněk, Keřkovský Miloš, Koukalová Renata, Zdražilová Dubská Lenka, Čechová Barbora, Král Zdeněk2024-12-15:Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenströ
Keywords: Waldenström’s macroglobulinemia – bortezomib – ixazomib
Authors: Adam Zdeněk, Krejčí Marta, Pour Luděk, Weinbergerová Barbora, Sandecká Viera, Štork Martin, Boichuk Ivanna, Řehák Zdeněk, Keřkovský Miloš, Koukalová Renata, Zdražilová Dubská Lenka, Čechová Barbora, Král Zdeněk2024-12-15:Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenströ
Klin Onkol 2024; 37(6): 463-466.
DOI: 10.48095/ccko2024463.
Keywords: bronchogenic cyst – mediastinal tumor – computed tomography – resection
Authors: Matsumoto Hiroaki, Hasegawa Sache, Maezawa Yosuke, Okauchi Shinichiro, Ohara Gen, Iguchi Kesato, Kawai Hitomi, Takayashiki Norio, Satoh Hiroaki2024-12-15:An atypical presentation of bronchogenic cyst
Keywords: bronchogenic cyst – mediastinal tumor – computed tomography – resection
Authors: Matsumoto Hiroaki, Hasegawa Sache, Maezawa Yosuke, Okauchi Shinichiro, Ohara Gen, Iguchi Kesato, Kawai Hitomi, Takayashiki Norio, Satoh Hiroaki2024-12-15:An atypical presentation of bronchogenic cyst
Klin Onkol 2024; 37(Suppl 1): 112-118.
DOI: 10.48095/ccko2024S1112.
Keywords: breast neoplasm – exercise – predictors – supporting factors – barriers
Authors: Burešová Iva, Halámková Jana, Kiss Igor, Hrnčiříková Iva, Kapounková Kateřina, Ziklová Anna, Kapounková Karolína2024-10-21:Predictors of maintaining motivation to exercise in women with breast cancer – preliminary results of a qualitative study
Keywords: breast neoplasm – exercise – predictors – supporting factors – barriers
Authors: Burešová Iva, Halámková Jana, Kiss Igor, Hrnčiříková Iva, Kapounková Kateřina, Ziklová Anna, Kapounková Karolína2024-10-21:Predictors of maintaining motivation to exercise in women with breast cancer – preliminary results of a qualitative study
Klin Onkol 2024; 37(Suppl 1): 119-122.
DOI: 10.48095/ccko2024S1119.
Keywords: pegfilrastim – lipegfilgrastim – neutropenia – prevention – side effects
Authors: Vokurka Samuel, Kliment Vojtěch, Kulhánková Jana, Votavová Marie, Janková Zuzana , Šorejs Ondřej, Fiala Ondřej, Fínek Jindřich2024-10-21:Trends of the use of pegylated granulopoiesis growth factors in clinical practice – single oncology centre experience since 2005
Keywords: pegfilrastim – lipegfilgrastim – neutropenia – prevention – side effects
Authors: Vokurka Samuel, Kliment Vojtěch, Kulhánková Jana, Votavová Marie, Janková Zuzana , Šorejs Ondřej, Fiala Ondřej, Fínek Jindřich2024-10-21:Trends of the use of pegylated granulopoiesis growth factors in clinical practice – single oncology centre experience since 2005
Klin Onkol 2024; 37(5): 324-330.
DOI: 10.48095/ccko2024324.
Keywords: breast cancer – cardiovascular disease – dyslipidemia – chemotherapy
Authors: Rušinová Lenka, Kozárová Miriam, Bavoľárová – Valíková Marcela2024-10-15:The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases
Keywords: breast cancer – cardiovascular disease – dyslipidemia – chemotherapy
Authors: Rušinová Lenka, Kozárová Miriam, Bavoľárová – Valíková Marcela2024-10-15:The dyslipidemic effect of cytostatics in the treatment of early breast cancer as a serious risk factor of cardiovascular diseases
Klin Onkol 2024; 37(5): 331-334.
DOI: 10.48095/ccko2024331.
Keywords: pancreatic cancer – gemcitabine/nab-paclitaxel – FOLFIRINOX – GENERATE study – nanoliposomal irinotecan
Authors: Tomášek Jiří2024-10-15:Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
Keywords: pancreatic cancer – gemcitabine/nab-paclitaxel – FOLFIRINOX – GENERATE study – nanoliposomal irinotecan
Authors: Tomášek Jiří2024-10-15:Gemcitabine/nab-paclitaxel in first line treatment of advanced pancreatic cancer – head-to-head comparison with the mFOLFIRINOX regimen
Klin Onkol 2024; 37(5): 335-344.
DOI: 10.48095/ccko2024335.
Keywords: anal cancer – radiotherapy – concurrent chemoradiotherapy – side effects – treatment effectiveness
Authors: Pechačová Zdeňka, Lohynská Radka, Šantrůčková Šárka, Šubrt Adam, Drbohlavová Tereza, Pála Miloslav2024-10-15:Accelerated radiotherapy in the treatment of anal squamous cell carcinoma – a single institution retrospective evaluation
Keywords: anal cancer – radiotherapy – concurrent chemoradiotherapy – side effects – treatment effectiveness
Authors: Pechačová Zdeňka, Lohynská Radka, Šantrůčková Šárka, Šubrt Adam, Drbohlavová Tereza, Pála Miloslav2024-10-15:Accelerated radiotherapy in the treatment of anal squamous cell carcinoma – a single institution retrospective evaluation
Klin Onkol 2024; 37(5): 345-353.
DOI: 10.48095/ccko2024345.
Keywords: targeted therapy – cancer – malignant tumor – nanomedicine – Brdička’s reaction
Authors: Melich Luděk, Werle Julia, Fořtová Magda , Vysloužilová. Lenka, Burešová Kristýna, Kotaška Karel, Klapková Eva, Štěpánková Olga, Čepová Jana, Průša Richard, Kizek René2024-10-15:Analysis of metalothionein in patients with malignant liver tumors
Keywords: targeted therapy – cancer – malignant tumor – nanomedicine – Brdička’s reaction
Authors: Melich Luděk, Werle Julia, Fořtová Magda , Vysloužilová. Lenka, Burešová Kristýna, Kotaška Karel, Klapková Eva, Štěpánková Olga, Čepová Jana, Průša Richard, Kizek René2024-10-15:Analysis of metalothionein in patients with malignant liver tumors
Klin Onkol 2024; 37(5): 354-369.
DOI: 10.48095/ccko2024354.
Keywords: retroperitoneal fibrosis – IgG4-related disease – rituximab – cyclophosphamide – circulating plasmablasts
Authors: Čermák Aleš, Foukal Jakub, Řehák Zdeněk, Adam Zdeněk, Keřkovský Miloš, Hruška Lukáš, Borský Marek, Doubek Michael, Vlažný Jakub, Pavlovský Zdeněk, Chovancová Zita, Boichuk Ivanna, Štork Martin, Pour Luděk, Koukalová Renata, Tomíška Miroslav, Král Zdeněk2024-10-15:Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone,
Keywords: retroperitoneal fibrosis – IgG4-related disease – rituximab – cyclophosphamide – circulating plasmablasts
Authors: Čermák Aleš, Foukal Jakub, Řehák Zdeněk, Adam Zdeněk, Keřkovský Miloš, Hruška Lukáš, Borský Marek, Doubek Michael, Vlažný Jakub, Pavlovský Zdeněk, Chovancová Zita, Boichuk Ivanna, Štork Martin, Pour Luděk, Koukalová Renata, Tomíška Miroslav, Král Zdeněk2024-10-15:Treatment of retroperitoneal fibrosis with rituximab, cyclophosphamide and dexamethasone,
Klin Onkol 2024; 37(5): 370-374.
DOI: 10.48095/ccko2024370.
Keywords: rectal cancer – total neoadjuvant therapy – immunotherapy – checkpoint inhibitors – microsatellite instability (MSI) – deficient mismatch repair (dMMR)
Authors: Křivonosková Soňa, Opluštilová Anna, Levý Miroslav, Komár Martin, Rosová Blanka, Lohynská Radka, Boublíková Ludmila2024-10-15:Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case report
Keywords: rectal cancer – total neoadjuvant therapy – immunotherapy – checkpoint inhibitors – microsatellite instability (MSI) – deficient mismatch repair (dMMR)
Authors: Křivonosková Soňa, Opluštilová Anna, Levý Miroslav, Komár Martin, Rosová Blanka, Lohynská Radka, Boublíková Ludmila2024-10-15:Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case report
Klin Onkol 2024; 37(5): 375-379.
DOI: 10.48095/ccko2024375.
Keywords: checkpoint inhibitor – chronické onemocnění ledvin – karcinom plic – dlaždicobuněčný karcinom
Authors: Matsumoto Hiroaki, Maezawa Yosuke, Ohara Gen, Shiozawa Toshihiro, Masuko Hironori, Satoh Hiroaki2024-10-15:Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
Keywords: checkpoint inhibitor – chronické onemocnění ledvin – karcinom plic – dlaždicobuněčný karcinom
Authors: Matsumoto Hiroaki, Maezawa Yosuke, Ohara Gen, Shiozawa Toshihiro, Masuko Hironori, Satoh Hiroaki2024-10-15:Long-term control by immune checkpoint inhibitors in a lung cancer patient with chronic kidney disease
Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Klin Onkol 2024; 37(5): 380-383.
DOI: 10.48095/ccko2024380.
Keywords: checkpoint inhibitors – pembrolizumab – drug side effects – pneumonitis – non-small cell lung carcinoma
Authors: Podhorec Ján, Jakubíková Lenka, Bílek Ondřej, Kiss Igor, Poprach Alexandr2024-10-15:Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Keywords: checkpoint inhibitors – pembrolizumab – drug side effects – pneumonitis – non-small cell lung carcinoma
Authors: Podhorec Ján, Jakubíková Lenka, Bílek Ondřej, Kiss Igor, Poprach Alexandr2024-10-15:Viral pneumonia in a patient treated with pembrolizumab – similarity with immune-related pneumonitis
Klin Onkol 2024; 37(5): 384-389.
DOI: 10.48095/ccko2024384.
Keywords: MLH1 – MSH2/EPCAM – MSH6 – PMS2 – consensus – guidelines for clinical practice – germline mutation carriers
Authors: Novotný Jan, Cibula David, Curtisová Václava, Dubová Oľga, Foretová Lenka, Germanová Anna , Janatová Markéta, Havránek Ondřej, Hojsáková Markéta, Hudcová Markéta, Koudová Monika, Krutílková Věra, Palácová Markéta, Paulich Sviatlana , Petráková Katarína, Presl Jiří, Puchmajerová Alena, Soukupová Jana, Šenkeříková Mária, Šimková Zuzana, Štěpánková Helena, Šubrt Ivan, Tachecí Ilja, Tesner Pavel, Urban Ondřej, Veselá Kamila, Vilímová Šárka, Vlčková Zdeňka, Vočka Michal, Weinberger Vít, Zikán Michal, Zimovjanová Martina, Kleibl Zdeněk, Kleiblová Petra2024-10-15:The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)
Keywords: MLH1 – MSH2/EPCAM – MSH6 – PMS2 – consensus – guidelines for clinical practice – germline mutation carriers
Authors: Novotný Jan, Cibula David, Curtisová Václava, Dubová Oľga, Foretová Lenka, Germanová Anna , Janatová Markéta, Havránek Ondřej, Hojsáková Markéta, Hudcová Markéta, Koudová Monika, Krutílková Věra, Palácová Markéta, Paulich Sviatlana , Petráková Katarína, Presl Jiří, Puchmajerová Alena, Soukupová Jana, Šenkeříková Mária, Šimková Zuzana, Štěpánková Helena, Šubrt Ivan, Tachecí Ilja, Tesner Pavel, Urban Ondřej, Veselá Kamila, Vilímová Šárka, Vlčková Zdeňka, Vočka Michal, Weinberger Vít, Zikán Michal, Zimovjanová Martina, Kleibl Zdeněk, Kleiblová Petra2024-10-15:The guidelines for clinical practice for carriers of germline mutations in the Lynch syndrome predisposition genes MLH1, MSH2, MSH6, PMS2 and large deletions of EPCAM (4.2024)